<DOC>
	<DOCNO>NCT02632175</DOCNO>
	<brief_summary>This study assess long-term safety efficacy adalimumab pediatric subject ulcerative colitis .</brief_summary>
	<brief_title>Long-term Safety Efficacy Study Adalimumab Pediatric Subjects With Ulcerative Colitis</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<mesh_term>Adalimumab</mesh_term>
	<criteria>Subject must successfully enrol complete M11290 study Subject consider investigator , reason , unsuitable candidate</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Ulcerative Colitis</keyword>
</DOC>